EAM Investors LLC decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 23.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,785 shares of the company’s stock after selling 12,256 shares during the period. EAM Investors LLC owned 0.07% of HealthEquity worth $2,063,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of HealthEquity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after buying an additional 1,308 shares during the period. Riverhead Capital Management LLC grew its stake in shares of HealthEquity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after buying an additional 1,129 shares during the period. Oppenheimer Asset Management Inc. grew its stake in shares of HealthEquity by 7.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock valued at $134,000 after buying an additional 191 shares during the period. Fortaleza Asset Management Inc. purchased a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $138,000. Finally, Creative Planning grew its stake in shares of HealthEquity by 94.4% in the 2nd quarter. Creative Planning now owns 3,274 shares of the company’s stock valued at $163,000 after buying an additional 1,590 shares during the period. 93.19% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “EAM Investors LLC Reduces Position in HealthEquity, Inc. (HQY)” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://ledgergazette.com/2017/11/24/eam-investors-llc-reduces-position-in-healthequity-inc-hqy.html.
A number of equities analysts recently weighed in on HQY shares. BidaskClub cut shares of HealthEquity from a “sell” rating to a “strong sell” rating in a research report on Friday, August 25th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price objective on shares of HealthEquity in a research report on Tuesday, September 5th. Zacks Investment Research cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Friday, November 3rd. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and set a $61.00 price objective on shares of HealthEquity in a research report on Wednesday, September 6th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $57.50.
In other HealthEquity news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction that occurred on Monday, November 20th. The shares were sold at an average price of $49.68, for a total transaction of $471,960.00. Following the sale, the vice president now directly owns 93,500 shares in the company, valued at approximately $4,645,080. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Berkley Capital, Llc sold 23,479 shares of the stock in a transaction that occurred on Thursday, November 16th. The stock was sold at an average price of $51.08, for a total transaction of $1,199,307.32. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,587,770 shares of company stock worth $82,827,759. 29.00% of the stock is owned by company insiders.
HealthEquity, Inc. (NASDAQ:HQY) opened at $50.90 on Friday. The firm has a market cap of $3,078.88, a P/E ratio of 80.79, a P/E/G ratio of 2.23 and a beta of 1.77. HealthEquity, Inc. has a 1 year low of $37.62 and a 1 year high of $55.31.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The firm’s quarterly revenue was up 28.7% on a year-over-year basis. During the same quarter last year, the company posted $0.16 EPS. analysts predict that HealthEquity, Inc. will post 0.7 earnings per share for the current year.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.